Common Contracts

3 similar Material Transfer and Option Agreement contracts by Coya Therapeutics, Inc.

MATERIAL TRANSFER AND OPTION AGREEMENT Carnegie Mellon University – Coya Therapeutics
Material Transfer and Option Agreement • December 5th, 2022 • Coya Therapeutics, Inc. • Pharmaceutical preparations

This Agreement (hereinafter this “Agreement”) is made and entered into this 24th day of June 2022 (“Effective Date”) by and between Carnegie Mellon University (hereinafter “Carnegie Mellon”), a Pennsylvania non-profit corporation having a principal place of business at 5000 Forbes Avenue, Pittsburgh, Pennsylvania 15213 and Coya Therapeutics, Inc., a Delaware corporation having a principal place of business at 5850 San Felipe St. Suite 500; Houston, TX 77057 (“Licensee”).

AutoNDA by SimpleDocs
MATERIAL TRANSFER AND OPTION AGREEMENT Carnegie Mellon University – Coya Therapeutics
Material Transfer and Option Agreement • November 18th, 2022 • Coya Therapeutics, Inc. • Pharmaceutical preparations • Pennsylvania

This Agreement (hereinafter this “Agreement”) is made and entered into this 24th day of June 2022 (“Effective Date”) by and between Carnegie Mellon University (hereinafter “Carnegie Mellon”), a Pennsylvania non-profit corporation having a principal place of business at 5000 Forbes Avenue, Pittsburgh, Pennsylvania 15213 and Coya Therapeutics, Inc., a Delaware corporation having a principal place of business at 5850 San Felipe St. Suite 500; Houston, TX 77057 (“Licensee”).

MATERIAL TRANSFER AND OPTION AGREEMENT Carnegie Mellon University – Coya Therapeutics
Material Transfer and Option Agreement • October 28th, 2022 • Coya Therapeutics, Inc. • Pharmaceutical preparations • Pennsylvania

This Agreement (hereinafter this “Agreement”) is made and entered into this 24th day of June 2022 (“Effective Date”) by and between Carnegie Mellon University (hereinafter “Carnegie Mellon”), a Pennsylvania non-profit corporation having a principal place of business at 5000 Forbes Avenue, Pittsburgh, Pennsylvania 15213 and Coya Therapeutics, Inc., a Delaware corporation having a principal place of business at 5850 San Felipe St. Suite 500; Houston, TX 77057 (“Licensee”).

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!